Experience and yield of mass breast screening among working women in major cities of India: a mixed-method study
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20204316Keywords:
Breast cancer, iBreastTM exam, MammographyAbstract
Background: iBreastTM tool is simple, safe, a handy device which is designed for mass breast cancer screening tool in a community or hospital setting. This study determined the yield and basic characteristics of women attending the breast cancer screening programme. The study also determined the overall experience of women who underwent breast cancer screening using iBreastTM tool.
Methods: This study was a multicentric, retrospective observational study conducted in Mumbai, Bangalore, Chennai and Hyderabad as a part of routine work-place breast cancer screening programme supported by Mfine. Screening was done by iBreastTM, which is a hand-held compression device. After proper clinical examination and iBreastTM scanning, results were confirmed by a consultant trained in interpretation of findings. The overall experience of the women who underwent screening was also determined using a questionnaire. Descriptive analysis was carried out by mean and standard deviation for quantitative variables, frequency and proportion for categorical variables. The qualitative assessment and thematic analysis of the qualitative data was done.
Results: A total of 1080 eligible female employees were present in the approached IT companies and out of that 451 women (41.75%) had consented and participated in the screening program. The acceptance rate was highest in Bengaluru city (65%) followed by Mumbai (53%), Chennai (33%) and least in Hyderabad (18%). 31 participants documented positive findings had in the scan and were referred for further evaluation. The quantitative and qualitative data determined that iBreastTM scan was highly accepted by all participants. Customer service, screening location and overall experience was deemed good by the participants with an average score of 4.8.
Conclusions: The iBreastTM has the potential to be a promising tool in providing effective diagnosis after breast examinations.
References
Malvia S, Bagadi SA, Dubey US, Saxena S. Epidemiology of breast cancer in Indian women. Asia Pac J Clin Oncol 2017;13(4):289-95.
WHO. Breast Cancer Awareness Month 2019.: WHO; 2019. Available at: https://www.iarc.fr/featured-news/breast-cancer-awareness-month-2019/. Accessed on 15 May 2020.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136(5):E359-86.
Shrivastava SR, Shrivastava PS, Ramasamy J. Self Breast Examination: A Tool for Early Diagnosis of Breast Cancer. Am J Public Health Res 2013;1(6):135-9.
Kumar JU, Sreekanth V, Reddy HR, Sridhar AB, Kodali N, Prabhu AS. Screening Mammography: A Pilot Study on Its Pertinence in Indian Population by Means of a Camp. J Clin Diagn Res 2017;11(8):29-32.
Grosse Frie K, Ramadas K, Anju GA, Mathew BS, Muwonge R, Sauvaget CS, et al. Determinants of participation in a breast cancer screening trial in trivandrum district, India. Asian Pac J Cancer Prev 2013;14(12):7301-7.
Gangane N, Ng N, Sebastian MS. Women's Knowledge, Attitudes, and Practices about Breast Cancer in a Rural District of Central India. Asian Pac J Cancer Prev 2015;16(16):6863-70.
Anderson BO, Cazap E, El Saghir NS, Yip CH, Khaled HM, Otero IV, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol 2011;12(4):387-98.
Bhattacharya S, Sharma N, Singh A. Designing culturally acceptable screening for breast cancer through artificial intelligence-two case studies. J Family Med Prim Care 2019;8(2):760-2.
Kr A. Non-invasive and low-cost technique for early detection of clinically relevant breast lesions using a handheld point-of-care medical device (iBreast): Prospective three-arm triple-blinded comparative study for breast cancer screening in low resource setting countries. Annals of Oncology. 2019;30(Supplement_3).
Jahagirdar D, Upganla P. Study of accuracy of ibreast exam lump-experience of a tert. IJCIR 2019;5(2(A):1462-6.
Pilevarzadeh M. Women's Perspective of Breast Self-examination. Int J Biomed Sci 2016;12(3):115-9.
Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Prabhakar J, Augustine P, et al. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst 2011;103(19):1476-80.
Shridhar K, Dey S, Bhan CM, Bumb D, Govil J, Dhillon PK. Cancer detection rates in a population-based, opportunistic screening model, New Delhi, India. Asian Pac J Cancer Prev 2015;16(5):1953-8.
Mallath MK, Taylor DG, Badwe RA, Rath GK, Shanta V, Pramesh CS, et al. The growing burden of cancer in India: epidemiology and social context. Lancet Oncol 2014;15(6):e205-12.
Vidyarthi A, Soumya A, Choudhary S, Sinha B. Barriers to breast cancer screening in young Indian women: A tale of two cities. Asian J Exp Sci 2013;27:29-35.
Khandelwal R. Health worker led breast examination in rural India using electro-mechanical hand-held breast palpation device. J Cancer Prev Curr Res 2018;9(3):138-41.
Kerlikowske K, Smith-Bindman R, Abraham LA, Lehman CD, Yankaskas BC, Ballard-Barbash R, et al. Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up. Radiol 2005;234(3):684-92.
Broach RB, Geha R, Englander BS, DeLaCruz L, Thrash H, Brooks AD. A cost-effective handheld breast scanner for use in low-resource environments: a validation study. World J Surg Oncol 2016;14(1):277.
RamBihariLal Shrivastava S, Saurabh Shrivastava P, Ramasamy J. Self Breast Examination: A Tool for Early Diagnosis of Breast Cancer. Am J Public Health Res 2013;1(6):135-9.
Fotedar V, Seam RK, Gupta MK, Gupta M, Vats S, Verma S. Knowledge of risk factors and early detection methods and practices towards breast cancer among nurses in Indira Gandhi Medical College, Shimla, Himachal Pradesh, India. Asian Pac J Cancer Prev 2013;14(1):117-20.
